Cann Global Limited

ASX:CGB ISIN:AU0000038085

Cann Global Limited ASX:CGBCann Global Limited's (ASX:CGB) primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets.

Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group.

The Group also retains an interest in its existing Bauxite Projects.

    

News

Cann Global Limited (ASX:CGB) Reinstatement Update

🕔8/16/2019 1:35:57 PM 1860

Cann Global Limited (ASX:CGB) provides the following update in connection with the reinstatement to quotation of the Company's fully paid Ordinary Shares.

Read Full Article

Cann Global Limited (ASX:CGB) Reinstatement Update

🕔8/9/2019 12:14:45 PM 3095

Cann Global Limited (ASX:CGB) provides the following update in connection with the reinstatement to quotation of the Company's fully paid Ordinary Shares.

Read Full Article

Cann Global Limited (ASX:CGB) Board Changes and Directors Interest Notices

🕔8/1/2019 4:41:40 PM 2077

As foreshadowed in the Company's announcement dated 15 May 2019, Cann Global Limted (ASX:CGB) confirms that the appointments of David Austin, Jonathan Cohen and John Easterling as independent directors took effect upon approval by Shareholders at the 2 July 2019 General Meeting.

Read Full Article

Cann Global Limited (ASX:CGB) Market Update

🕔7/12/2019 8:57:32 AM 2682

Cann Global Limited (ASX:CGB) is pleased to advise that the company is in the process of providing the ASX with all the paperwork confirming completion of all the transactions, completion of all the share issues, receipt of all the required escrow agreements, and the related required relisting documentation.

Read Full Article
###

5,066 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 239) (Last 30 Days: 1024) (Since Published: 5066) 

Company Data

    Headquarters
  • Level 21, 133 Castlereagh Street
    Sydney NSW 2023
    Australia
  • Telephone
  • +61-2-8379-1832 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.canngloballimited.com
  • E:
  • media@canngloballimited.com

Company Reports

Quarterly Report

Social Media